Search

Search Results

1. Radionuclide Therapy

   The main purpose of this book is to create a reference for the indications, contraindications, patient selection, treatment practice, treatment side...

   Recep Bekiş, Berna Polack, Murat Fani Bozkurt

   Book 2022
   

2. Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update

   Cancer therapy-induced cardiotoxicity is an emerging clinical and healthcare issue. Myocardial dysfunction and heart failure are mostly responsible...

   Cinzia Valzania, Andrea Paccagnella, ... Nazzareno Galié in Journal of Nuclear Cardiology

   Article 28 February 2023
   

3. Radionuclide-based theranostics — a promising strategy for lung cancer

   Purpose

   This review aims to provide a comprehensive overview of the latest literature on personalized lung cancer management using different ligands...

   Tianxing Zhu, Jessica C. Hsu, ... Kai Wang in European Journal of Nuclear Medicine and Molecular Imaging

   Article 16 March 2023
   

4. Radionuclide Imaging of the Neuroanatomical and Neurochemical Substrate of Cognitive Decline in Parkinson’s Disease

   Cognitive impairment is a frequent manifestation of Parkinson’s disease (PD), resulting in decrease in patients’ quality of life and increased...

   Samuel Booth, Ji Hyun Ko in Nuclear Medicine and Molecular Imaging

   Article 15 February 2024
   

5. Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors

   Purpose of Review

   To provide insights into the role of peptide receptor radionuclide therapy (PRRT) in patients with advanced neuroendocrine tumors...

   Denise S. Hoogenkamp, Linda J. de Wit–van der Veen, ... Arthur J. A. T. Braat in Current Oncology Reports

   Article Open access 10 April 2024
   

6. Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update

   Purpose of Review

   This paper aims to address the latest findings in neuroendocrine tumor (NET) theranostics, focusing on new evidence and future...

   Martina Di Franco, Lucia Zanoni, ... Valentina Ambrosini in Current Oncology Reports

   Article Open access 06 April 2024
   

7. Production of the PET radionuclide ⁶¹Cu via the ⁶²Ni(p,2n)⁶¹Cu nuclear reaction

   Background

   There are only a handful of true theranostic matched pairs, and in particular the theranostic radiocopper trio ⁶¹ Cu, ⁶⁴ Cu and ⁶⁷ Cu, for...

   Santiago Andrés Brühlmann, Martin Walther, ... Martin Kreller in EJNMMI Radiopharmacy and Chemistry

   Article Open access 05 January 2024
   

8. Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuclide therapy

   Background

   Peptide receptor radionuclide therapy is effective in treating neuroendocrine tumours, but treatment may be limited by kidney and bone...

   Märta Persson, Cecilia Hindorf, ... Joachim N. Nilsson in EJNMMI Research

   Article Open access 06 February 2024
   

9. Radionuclide Therapy Videos on YouTube as An Educational Material: Has the COVID-19 Pandemic Changed the Quality, Usefulness, and Interaction Features

   Introduction

   Current treatment approach aims to achieve greater efficacy with fewer side effects, by targeted cancer therapy as much as possible....

   Ulku Korkmaz, Selin Soyluoglu, Ersan Arda in Nuclear Medicine and Molecular Imaging

   Article 05 April 2023
   

10. EDB-FN targeted probes for the surgical navigation, radionuclide imaging, and therapy of thyroid cancer

    Purpose

    Extradomain B of fibronectin (EDB-FN) is a promising diagnostic and therapeutic biomarker for thyroid cancer (TC). Here, we identified a...

    Ru** Li, Huihui He, ... Wei Fan in European Journal of Nuclear Medicine and Molecular Imaging

    Article 18 February 2023
    

11. Repeat Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors: A NET Center of Excellence Experience

    Introduction

    The available data for the safety and efficacy of repeat peptide receptor radionuclide therapy (PRRT) are almost exclusively from...

    Udhayvir S. Grewal, Bradley T. Loeffler, ... Chandrikha Chandrasekharan in Journal of Gastrointestinal Cancer

    Article 23 May 2024
    

12. An antibody-radionuclide conjugate targets fibroblast activation protein for cancer therapy

    Purpose

    Fibroblast activation protein is one of the most attractive targets for tumor diagnosis and therapy. There have been many successful clinical...

    Mengxin Xu, Junyi Chen, ... Zhibo Liu in European Journal of Nuclear Medicine and Molecular Imaging

    Article 15 June 2023
    

13. Comparative evaluation of radionuclide therapy using ⁹⁰Y and ¹⁷⁷Lu

    Objective

    Both ⁹⁰ Y and ¹⁷⁷ Lu are attractive β-emitters for radionuclide therapy and have been used in clinical practice. Nevertheless, comparative...

    Hirofumi Hanaoka, Kazuyuki Hashimoto, ... Keigo Endo in Annals of Nuclear Medicine

    Article 09 November 2022
    

14. Single-centre experience with peptide receptor radionuclide therapy for neuroendocrine tumours (NETs): results using a theranostic molecular imaging-guided approach

    Aim

    To summarise our centre’s experience managing patients with neuroendocrine tumours (NETs) in the first 5 years after the introduction of peptide...

    S. Gordon, D. L. H. Chan, ... D. L. Bailey in Journal of Cancer Research and Clinical Oncology

    Article Open access 01 April 2023
    

15. Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine

    Targeted radionuclide theranostics is becoming more and more prominent in clinical oncology. Currently, most nuclear medicine compounds researched...

    Circe D. van der Heide, Simone U. Dalm in European Journal of Nuclear Medicine and Molecular Imaging

    Article Open access 05 July 2022
    

16. Liver-Directed Therapy for Neuroendocrine Tumor Metastases in the Era of Peptide Receptor Radionuclide Therapy

    The treatment of neuroendocrine neoplasm (NEN) liver metastases involves a multidisciplinary approach that includes liver-directed therapies (LDT)...

    Rana Rabei, Nicholas Fidelman in Current Treatment Options in Oncology

    Article Open access 15 December 2023

17. Ancillary radionuclide perfusion studies in the determination of death by neurologic criteria: methods, interpretation, and lexicon—a user guide for the clinician

    Radionuclide perfusion studies have an established ancillary role in determination of death by neurologic criteria (DNC). While critically important,...

    Lionel S. Zuckier, Nicole K. McKinnon in Canadian Journal of Anesthesia/Journal canadien d'anesthésie

    Article Open access 01 April 2023
    

18. Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies

    Introduction

    Fibroblast activation protein (FAP) is highly overexpressed in stromal tissue of various cancers. While FAP has been recognized as a...

    Bastiaan M. Privé, Mohamed A. Boussihmad, ... Harm Westdorp in European Journal of Nuclear Medicine and Molecular Imaging

    Article Open access 23 February 2023
    

19. KSNM60 in Non-thyroidal Radionuclide Therapy: Lea** into the Future

    This year, the Korean Society of Nuclear Medicine (KSNM) is celebrating its 60th anniversary. Treatment, as well as diagnosis, has played a very...

    Byung Hyun Byun, Myoung Hyoun Kim, ... Hwan-Jeong Jeong in Nuclear Medicine and Molecular Imaging

    Article 23 August 2021
    

20. Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles

    Purpose

    Currently, the most used peptide receptor radionuclide therapy (PRRT) regimen for neuroendocrine tumors comprises 4 treatment cycles, and...

    Richard P. Baum, **n Fan, ... **g**g Zhang in European Journal of Nuclear Medicine and Molecular Imaging

    Article 02 December 2023